Bill > SB0136

This bill introduces two new chapters to Indiana law focusing on prescription drug transparency and disclosure. The first chapter requires health plans (including state employee health plans, accident and sickness insurance policies, and individual/group health contracts) to provide the national average drug acquisition cost for generic drugs on written materials at the point of sale, starting January 1, 2026. The second chapter mandates that if a pharmacy benefit manager's agreement with a health plan allows less than 85% of estimated rebates to be deducted from prescription drug costs before calculating a patient's cost-sharing, the pharmacy benefit manager must provide the policyholder with an annual notice. This notice must explain what a rebate is, how rebates are accrued from manufacturers to health plans, and the total aggregate amount of rebates for prescription drugs dispensed under the policyholder's health plan in the previous year. The bill defines key terms like "rebate" (which includes discounts and price concessions paid by manufacturers after a claim is processed) and aims to increase transparency in how prescription drug costs are calculated and managed for patients.

Health and Social Services

https://iga.in.gov/legislative/2025/bills/senate/136/details